Julie Paul, MD
Rheumatology · Bel Air, MDNPI 1740741669
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $2,144 of the $2,421 with a category attached, or 88.6%. It is spread thinly across 17 manufacturers, the largest accounting for just 17.1% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for rheumatology clinicians in MD, where the typical reported total is $2,316.
Across 105 payments — averaging $23.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$414
- AbbVie$399
- UCB, Inc.$389
- Amgen$376
- Novartis$180
- Lilly USA, LLC$174
- plus $488 from 11 others
What the payments were for
- Food & beverage$2,14489%
- Education$27711%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 12 | $414 |
| AbbVie | 27 | $399 |
| UCB, Inc. | 11 | $389 |
| Amgen | 21 | $376 |
| Novartis | 7 | $180 |
| Lilly USA, LLC | 4 | $174 |
| Pfizer | 5 | $117 |
| AstraZeneca | 5 | $113 |
| Invivyd Inc | 2 | $57 |
| Aurinia Pharma U.S., Inc. | 2 | $49 |
| Radius Health, Inc. | 2 | $32 |
| Genentech USA, Inc. | 2 | $29 |
| GSK | 1 | $25 |
| Mallinckrodt Hospital Products Inc. | 1 | $19 |
| Sandoz | 1 | $16 |
| Organon | 1 | $15 |
| ANI Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$2,421 in reported general payments places this provider in the 50th percentile of 173 rheumatology providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MethotrexateMethotrexate Sodium | 22 | $567 |
| Prednisone | 44 | $384 |
Paid to pharmacies, not to this prescriber.
Other rheumatology in Bel Air
- Sumit KunwarBel Air$7K
- Evan SiegelRockville$594K
- Donald ThomasGreenbelt$471K
- Edmund MaclaughlinEaston$410K
- Michelle PetriBaltimore$381K
- Herbert BarafWheaton$268K
- Elizabeth ClaytonEaston$244K
- Alan MatsumotoWheaton$185K
- Nasser NasseriaslCatonsville$136K
- Marc HochbergBaltimore$124K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.